Integra LifeSciences
IART
186 hedge funds and large institutions have $2.12B invested in Integra LifeSciences in 2015 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 78 increasing their positions, 58 reducing their positions, and 26 closing their positions.
400% more funds holding in top 10
Funds holding in top 10: 1 → 5 (+4)
84% more call options, than puts
Call options by funds: $138K | Put options by funds: $75K
34% more repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 58
16% more capital invested
Capital invested by funds: $1.83B → $2.12B (+$294M)
8% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 26
2% less funds holding
Funds holding: 189 → 186 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$40.9M |
| 2 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$15.6M |
| 3 |
Norges Bank
Oslo,
Norway
|
+$10.8M |
| 4 |
O
OppenheimerFunds
New York
|
+$10.4M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$8.97M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VNIM
Vaughan Nelson Investment Management
Houston,
Texas
|
-$38.5M |
| 2 |
CI
Cambiar Investors
Denver,
Colorado
|
-$24M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$11.4M |
| 4 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
-$7.98M |
| 5 |
USAA
United Services Automobile Association
San Antonio,
Texas
|
-$6.2M |
IART Hedge Fund Activity: Q4 2015 in Review
186 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q4 2015, worth a combined $2.12B — up 16% from $1.83B a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of IART and 24 opened new positions — a net loss of 2 holders — while 58 trimmed existing stakes and 78 added.
The largest buyer was Wells Fargo, adding an estimated $40.9M. The largest seller was Vaughan Nelson Investment Management, cutting an estimated $38.5M.
- 186 institutional investors held Integra LifeSciences (IART) as of Q4 2015, down from 189 in Q3 2015.
- Funds reported $2.12B of Integra LifeSciences stock for Q4 2015, up 16% quarter-over-quarter.
- 24 funds opened new Integra LifeSciences positions in Q4 2015 and 26 closed out, a net change of -2 holders.
- The largest Integra LifeSciences buyer in Q4 2015 was Wells Fargo, an estimated $40.9M added.
- The largest Integra LifeSciences seller in Q4 2015 was Vaughan Nelson Investment Management, an estimated $38.5M sold.
Based on aggregated 13F filings for Q4 2015.